Skip to main content

Occurrence of Selected Generic Drugs 8

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    alosetron HCL
    alvimopan
    ambrisentan
    bosentan
    buprenorphine HCL
    bupropion HCL
    isotretinoin
    lenalidomide
    metoclopramide HCL
    naloxone HCL
    nilotinib HCL
    propoxyphene HCL
    propoxyphene HCL/acetaminophen
    propoxyphene HCL/ASA/caffeine
    ribavirin/interferon alfa-2B
    rosiglitazone/glimepiride
    rosiglitazone/metformin HCL
    sacrosidase
    sibutramine HCL
    thalidomide
    varenicline tartrate
    Description

    Summary table assessment of the use of 21 selected generic drug products including, Rosiglitazone/metformin hydrochloride (HCL), Rosiglitazone/Glimperide, Varenicline Tartrate, Propoxyphene HCL, Alvimopan, Isotretinoin, Ambrisentan, Alosetron HCL, Sibutramine Hydrochloride, Metoclopramide HCL, Lenalidomide, Buprenorphine HCL/Noloxone HCL, Buprenorphine HCL, Nilotinib Hydrochloride, Thalidomide, Bosentan, Burpopion HCL, Ribavirin/interferon A-2B, Sacrosidase, Propoxyphene HCL/Acetaminophen, and Propoxyphene HCL/ASA/Caffeine. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed in September-October 2012. This report includes data from 16 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    2004 - 2011
    Analysis Type
    Mini-Sentinel
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)